SCHEMBL7339647

SCHEMBL7339647

CCCCN1CCN=C1CN(Cc1cccc(OC)c1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.58
F2R P25116 3/20 0.43
SIGMAR1 Q99720 3/20 0.42
QPCT Q16769 1/20 0.41
OPRM1 P35372 1/20 0.41
CETP P11597 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CALM1 P0DP23 1/20 0.38
CAMKK2 Q96RR4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337887 0.94 DRD4 (0.55) DRD4F2RSIGMAR1QPCTOPRM1
SCHEMBL7342120 0.89 DRD4 (0.45) DRD4SIGMAR1OPRM1CHRM2CHRM1
SCHEMBL7348192 0.89 DRD4 (0.47) DRD4SIGMAR1CYP1A2CYP2D6
SCHEMBL7344285 0.87 CYP2D6 (0.47) DRD4OPRM1CYP1A2CYP2D6
SCHEMBL7339633 0.84 CYP1A2 (0.46) DRD4OPRM1CYP1A2CYP2D6
SCHEMBL7344567 0.83 CYP1A2 (0.47) DRD4SIGMAR1CYP1A2CYP2D6
SCHEMBL7343396 0.82 CYP1A2 (0.45) DRD4OPRM1CYP1A2CYP2D6
SCHEMBL7344115 0.82 CYP1A2 (0.45) DRD4OPRM1CYP1A2CYP2D6
SCHEMBL7337002 0.82 CYP1A2 (0.45) DRD4OPRM1CYP1A2CYP2D6
SCHEMBL7342001 0.80 CYP1A2 (0.41) CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0598962-B1 Imidazole derivatives as calcium channel blockers NEUROSEARCH AS (DK) 1999-02-17 EP claimed
EP-0598962-A1 Imidazole derivatives as calcium channel blockers NEUROSEARCH A/S (DK) 1994-06-01 EP disclosed
US-5296493-A Analgesics or antiischemics NEUROSEARCH A/S (DK) 1994-03-22 US disclosed